Dihydroxyanthraquinone and related Bis(Substituted) aminoanthraquinones: A novel class of antitumor agents-Reference-Cited by-同舟云学术

Dihydroxyanthraquinone and related Bis(Substituted) aminoanthraquinones: A novel class of antitumor agents

Published:1983-01 Issue:2 Volume:22 Page:199-214
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Traganos Frank

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference62 articles.

1. Daunomycin (NSC-82151) and adriamycin (NSC-123127): A hypothesis concerning antitumor activity and cardiotoxicity;Adamson;Cancer Chemother. Rep.,1974

2. Phase I clinical trial of Mitoxantrone: A new anthracenedione anticancer drug;Alberts;Cancer Chemother. Pharmac.,1980

3. Comparative-genotoxicity study of three aminoanthraquinone drugs and doxorubicin;Au;Cancer Res.,1981

4. Nuclear catalyzed antibiotic free radical formation;Bachur;Cancer Res.,1982

5. A general mechanism for microsomal activation of quinone anticancer agents to free radicals;Bachur;Cancer Res.,1978

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational Design, Synthesis, and DNA Binding Properties of Novel Sequence-Selective Peptidyl Congeners of Ametantrone;ChemMedChem;2010-05-10

2. The phenolic constituents and free radical scavenging activities ofGynura formosana Kiamnra;Journal of the Science of Food and Agriculture;2005

3. Antineoplastische Therapie;Praktische Arzneitherapie;2003

4. Antineoplastische Therapie;Praktische Arzneitherapie;2000

5. Ultrastructural nucleolar alterations induced by an ametantrone — poly r(A-U) complex;Tissue and Cell;1998-08